Acute severe asthma: Pathophysiology and pathobiology of gas exchange abnormalities

European Respiratory Journal

Volumn 10, Issue 6, 1997, Pages 1359-1371

  Rodriguez Roisin, R ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Airway mediators; Anti asthma drugs; Bronchial circulation; Fatal and near fatal asthma; Platelet activating factor; Ventilation perfusion mismatching

Indexed keywords

IPRATROPIUM BROMIDE; SALBUTAMOL; THROMBOCYTE ACTIVATING FACTOR;

ASTHMA; BLOOD FLOWMETRY; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXEMIA; LUNG VENTILATION PERFUSION RATIO; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY AIRFLOW; REVIEW;

ACUTE DISEASE; CAPILLARY PERMEABILITY; HUMANS; LUNG; PLATELET ACTIVATING FACTOR; PULMONARY GAS EXCHANGE; PULMONARY VENTILATION; STATUS ASTHMATICUS; VENTILATION-PERFUSION RATIO;

EID: 0030926531     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.97.10061359     Document Type: Review

References (82)

1. Rodriguez-Roisin R, Roca J. Contributions of multiple inert gas elimination technique to pulmonary medicine. 3. Bronchial asthma. Thorax 1994; 49: 1027-1033.
2. McFadden ER Jr, Hejal R. Asthma. Lancet 1995; 345: 1215-1220.
3. Molfino NA, Nannini LJ, Martelli AN, Slutsky AS. Respiratory arrest in near-fatal asthma. N Engl J Med 1991; 324: 285-288.
4. Rebuck AS, Read J. Assessment and management of severe asthma. Am J Med 1971; 51: 788-798.
5. Roca J, Ramis LI, Rodriguez-Roisin R, Ballester E, Montserrat JM, Wagner PD. Serial relationships between ventilation-perfusion inequality and spirometry in acute severe asthma requiring hospitalization. Am Rev Respir Dis 1988; 137: 1055-1061.
6. Ferrer A, Roca J, Wagner PD, Lopez FA, Rodriguez-Roisin R. Airway obstruction and ventilation-perfusion relationships in acute severe asthma. Am Rev Respir Dis 1993; 147: 579-584.
7. Mountain RD, Sahn SA. Clinical features and outcome in patients with acute asthma presenting with hypercapnia. Am Rev Respir Dis 1988; 138: 535-539.
8. Wasserfallen JB, Schaller MD, Feihl F, Perret C. Sudden asphyxie asthma: a distinct entity? Am Rev Respir Dis 1990; 142: 108-111.
9. Ferrer A, Torres A, Roca J, Sunyer J, Antó JM, Rodriguez-Roisin R. Characteristics of patients with soybean dust-induced acute severe asthma requiring mechanical ventilation. Eur Respir J 1990; 3: 429-433.
10. Murray V, Venables K, Laing-Morton T, Partridge M, Williams D. Epidemic of asthma possibly related to thunderstorms. BMJ 1994; 309: 131-132.
11. O'Hallaren MT, Yunginger JW, Offord KP, et al. Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med 1991; 324: 359-363.
12. Sur S, Crotty TB, Kephart GM, et al. Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa. Am Rev Respir Dis 1993; 148: 713-719.
13. Rodriguez-Roisin R, Torres A, Agusti AGN, Ussetti P, Agusti-Vidal A. Subconjunctival haemorrhage: a feature of acute severe asthma. Postgrad Med J 1983; 61: 579-581.
14. Dimond JP, Palazzo MGA. An unconscious man with asthma and a fixed, dilated pupil. Lancet 1997; 349: 98.
15. McFadden ER Jr, Lyons HA. Arterial blood gas tensions in asthma. N Engl J Med 1968; 278: 1027-1032.
16. Tai E, Read J. Arterial-blood gas tension in asthma. Lancet 1967; i: 644-646.
17. Mihatsch W, Geelhoed GC, Landau LI, LeSouëf PN. Time course of change in oxygen saturation and peak expiratory flow rate in children admitted to hospital with acute asthma. Thorax 1990; 45: 438-441.
18. Ballester E, Reyes A, Roca J, Guitart R, Wagner PD, Rodriguez-Roisin R. Ventilation-perfusion mismatching in acute severe asthma: effects of salbutamol and 100% oxygen. Thorax 1989; 44: 258-267.
19. Roca J, Wagner PD. Contributions of multiple inert gas elimination technique to pulmonary medicine. 1. Principles and information content of the multiple inert gas elimination technique. Thorax 1994; 49: 815-824.
20. Wagner PD, Hedenstierna G, Rodriguez-Roisin R. Gas exchange, expiratory flow obstruction and the clinical spectrum of asthma. Eur Respir J 1996; 9: 1278-1282.
21. Rodriguez-Roisin R, Ballester E, Torres A, Roca J, Wagner PD. Mechanisms of abnormal gas exchange in patients with status asthmaticus needing mechanical ventilation. Am Rev Respir Dis 1989; 139: 732-739.
22. Lee LN, Ueno O, Wagner PD, West JB. Pulmonary gas exchange after multiple airway occlusion by beads in the dog. Am Rev Respir Dis 1989; 140: 1216-1221.
23. Barberà JA, Roca J, Ferrer A, et al. Mechanisms of abnormal gas exchange during acute exacerbations of chronic obstructive pulmonary disease. Eur Respir J 1997; 10: 1285-1291.
24. West JB, Dollery CT, Naimark A. Distribution of blood flow in isolated lung: relation to vascular and alveolar pressures. J Appl Physiol 1964; 19: 713-724.
25. Freyschuss U, Hedelin G, Hedenstierna G. Ventilation-perfusion relationships during exercise-induced asthma in children. Am Rev Respir Dis 1984; 130: 888-894.
26. Agustí AGN, Barberà JA. Contributions of multiple inert gas elimination technique to pulmonary medicine. 2. Chronic pulmonary disease: chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Thorax 1994; 49: 924-932.
27. Rodriguez-Roisin R, Roca J. Gas exchange in COPD. In: Calverley PMA, Pride NB, eds. Chronic Obstructive Pulmonary Disease. London, Chapman & Hall, 1994; pp. 161-184.
28. Clayton RA, Nally JE, Thomson NC, McGrath JC. The effect of oxygen tension on responses evoked by methacholine and bronchodilators in isolated bovine bronchial rings. Pulm Pharmacol 1996; 9: 123-128.
29. Dagge KD, Thomson LJ, Ramsay SG, Thomson NC. Effect of acute hypoxia on the bronchodilator response to salbutamol in stable asthmatic patients. Thorax 1996; 51: 853-854.
30. Inoue H, Inoue C, Okayama M, Sekizawa K, Hida W, Takishima Y. Breathing 30 percent oxygen attenuates bronchial responsiveness to methacholine in asthmatic patients. Eur Respir J 1989; 2: 506-512.
31. Grant BJB, Fortune JB, West JB. Effect of local antigen inhalation and hypoxia on lobar blood flow in allergic dogs. Am Rev Respir Dis 1980; 122: 39-46.
32. 2 on ventilation and perfusion heterogeneity in hyperventilated dogs. J Appl Physiol 1993; 75: 1306-1314.
33. Brimioulle S, Kahn RJ. Effects of metabolic acidosis on pulmonary gas exchange. Am Rev Respir Dis 1990; 141: 1185-1189.
34. Nattie EE. Gas exchange in acid-base disturbances. In: Fahri LE, Tenney SM, eds. Handbook of Physiology. Vol. 4. The Respiratory System: Gas Exchange. Bethesda; American Physiological Society, 1987; pp. 421-438.
35. 2-or pH-mediated effect? Am J Respir Crit Care Med 1995; 152: 1534-1539.
36. Brimioulle S, Lejeune P, Vachiéry JL, Leeman M, Mélot C, Naeije R. Effect of acidosis and alkalosis on hypoxic pulmonary vasoconstriction in dogs. Am J Physiol 1990; 258: H347-H353.
37. Traystman RJ, Terry PB, Menkes HA. Carbon dioxide, a major determinant of collateral ventilation. J Appl Physiol: Respirat Environ Exercise Physiol 1978; 45: 69-74.
38. Rodriguez-Roisin R, Wagner PD. Clinical relevance of ventilation-perfusion inequality determined by inert gas elimination. Eur Respir J 1990; 3: 469-482.
39. Wagner PD, Rodriguez-Roisin R. Clinical advances in pulmonary gas exchange. Am Rev Respir Dis 1991; 143: 883-888.
40. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 343: 133-135.
41. Massaro AF, Gaston B, Kita D, Fanta C, Stamler JS, Drazen JM. Expired nitric oxide levels during treatment of acute asthma. Am J Respir Crit Care Med 1995; 152: 800-802.
42. Lagerstrand L, Dahlbäck M, Hedenstierna G. Gas exchange during simulated airway secretion in the anaesthesized rabbit. Eur Respir J 1992; 5: 1215-1222.
43. Dunnill MS. The pathology of asthma, with special reference to changes in the bronchial mucosa. J Clin Pathol 1960; 13: 27-33.
44. Saetta M, Di Stefano A, Rosina C, Thiene G, Fabbri LM. Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma. Am Rev Respir Dis 1991; 143: 138-143.
45. Reid LM. The presence or absence of bronchial mucus in fatal asthma. Allergy J Clin Immunol 1987; 80 (Suppl.): 415-419.
46. Barberà JA, Riverola A, Roca J, et al. Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 149: 423-429.
47. Kraft M, Djukanovic R, Wilson S, Holgate ST, Martin RJ. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med 1996; 154: 1505-1510.
48. Aikawa T, Shimura S, Sasaki H, Ebina M, Takishima T. Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of acute severe asthma attack. Chest 1992; 101: 916-921.
49. Azzawi M, Johnston PW, Majumdar S, Kay AB, Jeffery PK. T-lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis. Am Rev Respir Dis 1992; 145: 1477-1482.
50. Carroll N, Carello S, Cooke C, James A. Airway structure and inflammatory cells in fatal attacks of asthma. Eur Respir J 1996; 9: 709-715.
51. Synek M, Antó JM, Beasley R, et al. Immunopathology of fatal soybean dust-induced asthma. Eur Respir J 1996; 9: 54-57.
52. Shirasaki H, Nishikawa M, Adcock JM, et al. Expression of platelet-activating factor receptor mRNA in human and guinea-pigs. Am J Respir Cell Mol Biol 1994; 10: 533-537.
53. Félez MA, Roca J, Barberà JA, et al. Inhaled platelet-activating factor worsens gas exchange in mild asthma. Am J Respir Crit Care Med 1994; 150: 369-373.
54. Rodriguez-Roisin R, Félez MA, Chung FK, et al. Platelet-activating factor causes ventilation-perfusion mismatch in humans. J Clin Invest 1994; 93: 188-194.
55. Rodriguez-Roisin R, Ferrer A, Navajas D, Agustí AGN, Wagner PD, Roca J. Ventilation-perfusion mismatch after methacholine challenge in patients with mild bronchial asthma. Am Rev Respir Dis 1991; 144: 88-94.
56. Louis RE, Radermecker MF. Acute bronchial obstruction following inhalation of PAF in asthmatic and normal subjects: comparison with methacholine. Eur Respir J 1996; 9: 1414-1420.
57. Rubin AE, Smith LJ, Patterson R. The bronchoconstrictor properties of platelet-activating factor in humans. Am Rev Respir Dis 1987; 136: 1145-1151.
58. Schellenberg RR. Airway responses to platelet-activating factor. Am Rev Respir Dis 1987; 136: S28-S32.
59. Johnson PRA, Black JL, Armour CL. Platelet-activating factor-induced contraction of human isolated bronchus. Eur Respir J 1992; 5: 970-974.
60. Tam FWK, Clague J, Dixon CM, et al. Inhaled platelet-activating factor causes pulmonary neutrophil sequestration in normal humans. Am Rev Respir Dis 1992; 146: 1003-1008.
61. Masclans JR, Barberà JA, MacNee W, et al. Salbutamol reduces pulmonary neutrophil sequestration of platelet-activating factor in humans. Am J Respir Crit Care Med 1996; 154: 529-532.
62. Roca J, Félez MA, Chung KF, et al. Salbutamol inhibits pulmonary effects of platelet-activating factor in man. Am J Respir Crit Care Med 1995; 151: 1740-1745.
63. Díaz O, Barberà JA, Marrades R, Chung KF, Roca J, Rodriguez-Roisin R. Inhibition of PAF-induced gas exchange defects by beta-adrenergic agonists in mild asthma is not due to bronchodilation. Am J Respir Crit Care Med 1997; (In press).
64. Chung KF, Dent G, Barnes PJ. Effects of salbutamol on bronchoconstriction, bronchial hyperresponsiveness, and leucocyte responses induced by platelet-activating factor in man. Thorax 1988; 44: 102-107.
65. McDonald DM. Neurogenic inflammation in the respiratory tract: actions of the sensory nerve mediators on blood vessels and epithelium of the airway mucosa. Am Rev Respir Dis 1987; 136: S65-S67.
66. McDonald DM. The ultrastructure and permeability of tracheobronchial vessels in health and disease. Eur Respir J 1990; 3 (Suppl. 12): 572s-585s.
67. Persson CGA. Role of plasma exudation in asthmatic airways. Lancet 1986; ii: 1126-1128.
68. Persson CGA, Erjefält JS, Andersson M, Greiff L, Svensson C. Extravasation, Iamina propria and lumenal entry of bulk plasma in mucosal defence, inflammation and repair. Pulm Pharmacol 1996; 9: 129-139.
69. Yager D, Butler J, Bastacky J, Israel E, Smith G, Drazen JM. Amplification of airway constriction due to liquid filling of airway interstices. J Appl Physiol 1989; 66: 2873-2884.
70. Persson CGA. Plasma exudation and asthma. Lung 1988; 166: 1-23.
71. Wagner EW, Mitzner W. Effects of bronchial vascular engorgement on airway dimensions. J Appl Physiol 1996; 81: 293-301.
72. Erjefält JS, Svensjö E. Vascular responses and their suppression: drugs interfering with venular permeability. In: Bonta IL, Bray MA, Parnham MJ, eds. Handbook of Inflammation. Vol. 5. Amsterdam, Elsevier, 1985; pp. 61-82.
73. Erjefält JS, Persson CGA. Pharmacological control of plasma exudation into tracheobronchial airways. Am Rev Respir Dis 1991; 143: 1008-1014.
74. Sulakvelidze I, McDonald DM. Anti-edema action of formoterol in rat trachea does not depend on capsaicin-sensitive sensory nerves. Am J Respir Crit Care Med 1994; 149: 232-238.
75. 2-adrenoceptor agonists against platelet-activating factor-induced airway microvascular leakage in the guinea-pig. Agents Actions 1993; 40: 50-56.
76. Tokuyama K, Lötvall JO, Löfdahl CG, Barnes PJ, Chung KF. Inhaled formoterol inhibits histamine-induced airflow obstruction and airway microvascular leakage. Eur J Pharmacol 1991; 193: 35-39.
77. Spring J, Johnston SR, Seale J, Ind PW. Failure of salmeterol to inhibit white cell responses and bronchoconstriction induced by platelet-activating factor. Thorax 1992; 47: 948-951.
78. Kurosawa M, Yamashita T, Kurimoto F. Increased levels of platelet-activating factor in bronchial asthmatic patients with active symptoms. Allergy 1994; 49: 60-63.
79. Kue-Hsiung H, Cheng-Koon Ng. Increased plasma platelet-activating factor in children with acute asthmatic attacks and decreased in vivo and in vitro production of platelet-activating factor after immunotherapy. J Allergy Clin Immunol 1993; 91: 650-657.
80. Kuitert L, Barnes NC. PAF and asthma: time for appraisal? Clin Exp Allergy 1995; 25: 1159-1162.
81. Nadel JA. Genetics reveals importance of platelet-activating factor in asthma and possibly other inflammatory states. J Clin Invest 1996; 97: 2689-2690.
82. Drazen J. What are the clinical benefits of a selective approach? Eur Respir Rev 1994; 6: 402-404.